Femorose 500 mg is a nutraceutical capsule formulated with Evening Primrose Oil (EPO), a natural source of Gamma Linolenic Acid (GLA), an essential omega-6 fatty acid. It is widely used to support women’s health, particularly in conditions related to hormonal balance and essential fatty acid (EFA) deficiency. Femorose 500 mg plays an important role in maintaining normal cellular structure, supporting prostaglandin synthesis, and improving overall fatty acid metabolism in the body.
The therapeutic benefits of Femorose are mainly attributed to its GLA content. GLA is a precursor of dihomo-gamma-linolenic acid (DGLA), which is further involved in the formation of prostaglandins that regulate inflammation, pain, and hormonal responses. By supplying GLA directly, Femorose bypasses the rate-limiting metabolic step of converting linoleic acid (LA) to GLA, ensuring better bioavailability and clinical effectiveness.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Active Ingredient: Evening Primrose Oil equivalent to Gamma Linolenic Acid
Strength: 500 mg
Dosage Form: Capsule
Herbal and Nutraceuticals
Femorose 500 mg is indicated for the management and support of:
Premenstrual syndrome (PMS) symptoms
Cyclical mastalgia (breast pain associated with menstrual cycle)
Lactation support
Essential fatty acid deficiency states
Femorose 500 mg improves the essential fatty acid composition of plasma, erythrocytes, platelet lipids, and increases α-tocopherol levels. It has been shown to enhance total fat and EFA content in breast milk, making it beneficial during lactation. The supplied GLA is rapidly absorbed after oral administration and is directly converted into DGLA and other prostaglandin precursors, influencing the prostanoid pathway.
GLA and its metabolites help maintain normal cell membrane integrity and regulate inflammatory responses. In vitro studies have also demonstrated cytostatic activity on certain malignant cell lines, indicating its potential role in modulating abnormal cell proliferation.
Recommended Dose: One or two capsules, two to three times daily
Dosage may be adjusted according to individual needs or as advised by a physician
No clinically significant drug interactions are known
Steroids and nonsteroidal anti-inflammatory drugs (NSAIDs) may potentially interfere with essential fatty acid metabolism
Previously not recommended in patients with schizophrenia or those taking epileptogenic drugs such as phenothiazines
Recent clinical evidence does not indicate a clear adverse or therapeutic effect in schizophrenic patients
Femorose 500 mg is generally well tolerated at recommended doses. Rare adverse effects may include:
Loose stools
Mild abdominal discomfort (usually with overdose)
No known restrictions during pregnancy and lactation
Non-teratogenic based on animal studies
LA, GLA, and DGLA are natural components of human breast milk
According to the World Health Organization (WHO), pregnant and lactating women should obtain approximately 5% of total daily caloric intake from essential fatty acids
Store below 30°C
Protect from light and moisture
Keep out of the reach of children.
Login Or Registerto submit your questions to seller
No none asked to seller yet